Respiratory Syncytial Virus–Associated Hospitalizations Among Children Less Than 24 Months of Age
By C. Hall, G. Weinberg, Aaron K. Blumkin, K. Edwards, M. Staat, Andrew F. Schultz, K. Poehling, Peter G. Szilagyi, Marie R. Griffin, John V. Williams and 4 more. Pediatrics, 2013
612 citations recorded by the source corpus.
Subfields: Epidemiology, Immunology, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/31acbcb23a9642a6fdd2de737d44425067512cec
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
Citations in the corpus
- Iterative structure-based improvement of a respiratory syncytial virus fusion glycoprotein vaccine (2016, positive): “Premature infants born between 28 and 34 weeks gestation also have increased risk for severe RSV disease; and while full-term infants without identified risk factors do have reduced rates of severe RSV disease, these full-term infants nevertheless make up 50% of RSV-related hospitalizations 10 .”